MLAB Mesa Laboratories Inc

Price (delayed)

$322.5

Market cap

$1.68B

P/E Ratio

398.15

Dividend/share

$0.48

EPS

$0.81

Enterprise value

$1.57B

Mesa Labs is a global leader in the design and manufacturing of critical quality control solutions for the pharmaceutical, healthcare, medical device, industrial safety, environmental, and food and beverage industries. ...

Highlights
The gross profit has grown by 28% YoY and by 2.2% from the previous quarter
Mesa Laboratories's net income has increased by 24% QoQ
The company's quick ratio fell by 27% YoY
The debt has grown by 19% YoY and by 16% from the previous quarter

Key stats

What are the main financial stats of MLAB
Market
Shares outstanding
5.2M
Market cap
$1.68B
Enterprise value
$1.57B
Valuations
Price to earnings (P/E)
398.15
Price to book (P/B)
4.16
Price to sales (P/S)
11.96
EV/EBIT
157.96
EV/EBITDA
55.57
EV/Sales
11.31
Earnings
Revenue
$138.92M
EBIT
$9.95M
EBITDA
$28.27M
Free cash flow
$42.17M
Per share
EPS
$0.81
Free cash flow per share
$8.18
Book value per share
$77.61
Revenue per share
$26.96
TBVPS
$66.01
Balance sheet
Total assets
$612.49M
Total liabilities
$213.49M
Debt
$168.7M
Equity
$399M
Working capital
$281.86M
Liquidity
Debt to equity
0.42
Current ratio
9.43
Quick ratio
8.86
Net debt/EBITDA
-3.79
Margins
EBITDA margin
20.4%
Gross margin
64%
Net margin
2.9%
Operating margin
9.2%
Efficiency
Return on assets
0.7%
Return on equity
1%
Return on invested capital
5.1%
Return on capital employed
1.7%
Return on sales
7.2%
Dividend
Dividend yield
0.15%
DPS
$0.48
Payout ratio
59.3%

MLAB stock price

How has the Mesa Laboratories stock price performed over time
Intraday
0.02%
1 week
2.9%
1 month
20.78%
1 year
33.98%
YTD
12.51%
QTD
18.93%

Financial performance

How have Mesa Laboratories's revenue and profit performed over time
Revenue
$138.92M
Gross profit
$88.89M
Operating income
$12.81M
Net income
$4.05M
Gross margin
64%
Net margin
2.9%
MLAB's operating income has soared by 118% YoY and by 3.6% from the previous quarter
The operating margin has soared by 92% YoY
The gross profit has grown by 28% YoY and by 2.2% from the previous quarter
Mesa Laboratories's net income has increased by 24% QoQ

Growth

What is Mesa Laboratories's growth rate over time

Valuation

What is Mesa Laboratories stock price valuation
P/E
398.15
P/B
4.16
P/S
11.96
EV/EBIT
157.96
EV/EBITDA
55.57
EV/Sales
11.31
The company's EPS rose by 23% QoQ
MLAB's price to book (P/B) is 22% more than its last 4 quarters average of 3.4 but 19% less than its 5-year quarterly average of 5.1
MLAB's equity is up by 4.4% year-on-year
The P/S is 55% above the 5-year quarterly average of 7.7 and 18% above the last 4 quarters average of 10.1
MLAB's revenue is up by 14% year-on-year and by 3.7% since the previous quarter

Efficiency

How efficient is Mesa Laboratories business performance
Mesa Laboratories's return on invested capital has increased by 46% YoY but it has decreased by 6% QoQ
The return on assets has increased by 40% since the previous quarter
The company's return on sales rose by 36% YoY but it fell by 6% QoQ
MLAB's return on equity is up by 25% since the previous quarter

Dividends

What is MLAB's dividend history
DPS
$0.48
Dividend yield
0.15%
Payout ratio
59.3%
Recent dividends

Financial health

How did Mesa Laboratories financials performed over time
Mesa Laboratories's total assets is 187% more than its total liabilities
MLAB's current ratio is down by 28% year-on-year
The company's quick ratio fell by 27% YoY
The debt is 58% less than the equity
The debt has grown by 19% YoY and by 16% from the previous quarter
MLAB's debt to equity is up by 17% QoQ and by 14% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.